These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 27010986)

  • 1. Nanocarrier-based co-delivery of small molecules and siRNA/miRNA for treatment of cancer.
    Chitkara D; Singh S; Mittal A
    Ther Deliv; 2016; 7(4):245-55. PubMed ID: 27010986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances.
    Gandhi NS; Tekade RK; Chougule MB
    J Control Release; 2014 Nov; 194():238-56. PubMed ID: 25204288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stealth monoolein-based nanocarriers for delivery of siRNA to cancer cells.
    Oliveira AC; Raemdonck K; Martens T; Rombouts K; Simón-Vázquez R; Botelho C; Lopes I; Lúcio M; González-Fernández Á; Real Oliveira ME; Gomes AC; Braeckmans K
    Acta Biomater; 2015 Oct; 25():216-29. PubMed ID: 26225736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymers in the Co-delivery of siRNA and Anticancer Drugs for the Treatment of Drug-resistant Cancers.
    Sun H; Yarovoy I; Capeling M; Cheng C
    Top Curr Chem (Cham); 2017 Apr; 375(2):24. PubMed ID: 28176270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges.
    Gomes-da-Silva LC; Fonseca NA; Moura V; Pedroso de Lima MC; Simões S; Moreira JN
    Acc Chem Res; 2012 Jul; 45(7):1163-71. PubMed ID: 22568781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanocarriers for delivery of siRNA and co-delivery of siRNA and other therapeutic agents.
    Zhao J; Feng SS
    Nanomedicine (Lond); 2015 Jul; 10(14):2199-228. PubMed ID: 26214357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of lung cancer multidrug resistance by pH-responsive micelleplexes mediating co-delivery of siRNA and paclitaxel.
    Yu H; Xu Z; Chen X; Xu L; Yin Q; Zhang Z; Li Y
    Macromol Biosci; 2014 Jan; 14(1):100-9. PubMed ID: 23966347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nano carriers that enable co-delivery of chemotherapy and RNAi agents for treatment of drug-resistant cancers.
    Tsouris V; Joo MK; Kim SH; Kwon IC; Won YY
    Biotechnol Adv; 2014; 32(5):1037-50. PubMed ID: 24924617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-targeting multifunctional nanoparticles for siRNA delivery: recent advances in cancer therapy.
    Ku SH; Kim K; Choi K; Kim SH; Kwon IC
    Adv Healthc Mater; 2014 Aug; 3(8):1182-93. PubMed ID: 24577795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonviral pulmonary delivery of siRNA.
    Merkel OM; Kissel T
    Acc Chem Res; 2012 Jul; 45(7):961-70. PubMed ID: 21905687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overcoming drug resistance of MCF-7/ADR cells by altering intracellular distribution of doxorubicin via MVP knockdown with a novel siRNA polyamidoamine-hyaluronic acid complex.
    Han M; Lv Q; Tang XJ; Hu YL; Xu DH; Li FZ; Liang WQ; Gao JQ
    J Control Release; 2012 Oct; 163(2):136-44. PubMed ID: 22940126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modular degradable dendrimers enable small RNAs to extend survival in an aggressive liver cancer model.
    Zhou K; Nguyen LH; Miller JB; Yan Y; Kos P; Xiong H; Li L; Hao J; Minnig JT; Zhu H; Siegwart DJ
    Proc Natl Acad Sci U S A; 2016 Jan; 113(3):520-5. PubMed ID: 26729861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redox-responsive mesoporous silica nanoparticles: a physiologically sensitive codelivery vehicle for siRNA and doxorubicin.
    Ma X; Teh C; Zhang Q; Borah P; Choong C; Korzh V; Zhao Y
    Antioxid Redox Signal; 2014 Aug; 21(5):707-22. PubMed ID: 23931896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanocarriers in effective pulmonary delivery of siRNA: current approaches and challenges.
    Bardoliwala D; Patel V; Javia A; Ghosh S; Patel A; Misra A
    Ther Deliv; 2019 May; 10(5):311-332. PubMed ID: 31116099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo delivery of small interfering RNA to tumors and their vasculature by novel dendritic nanocarriers.
    Ofek P; Fischer W; Calderón M; Haag R; Satchi-Fainaro R
    FASEB J; 2010 Sep; 24(9):3122-34. PubMed ID: 20385622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing siRNA cancer therapy: Multifaceted strategies with lipid and polymer-based carrier systems.
    Dastgerdi NK; Dastgerdi NK; Bayraktutan H; Costabile G; Atyabi F; Dinarvand R; Longobardi G; Alexander C; Conte C
    Int J Pharm; 2024 Sep; 663():124545. PubMed ID: 39098747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient tuning of siRNA dose response by combining mixed polymer nanocarriers with simple kinetic modeling.
    Greco CT; Muir VG; Epps TH; Sullivan MO
    Acta Biomater; 2017 Mar; 50():407-416. PubMed ID: 28063990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoplexes versus nanoparticles: pDNA/siRNA delivery.
    Khurana B; Goyal AK; Budhiraja A; Aora D; Vyas SP
    Drug Deliv; 2013 Feb; 20(2):57-64. PubMed ID: 23537464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The synergistic effect of hierarchical assemblies of siRNA and chemotherapeutic drugs co-delivered into hepatic cancer cells.
    Cao N; Cheng D; Zou S; Ai H; Gao J; Shuai X
    Biomaterials; 2011 Mar; 32(8):2222-32. PubMed ID: 21186059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Preparative Approaches for Micro and Nano Drug Delivery Carriers.
    Bochicchio S; Dalmoro A; Barba AA; d'Amore M; Lamberti G
    Curr Drug Deliv; 2017; 14(2):203-215. PubMed ID: 27364732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.